Noble Capital Markets Initiates Equity Research Coverage on MariMed (MRMD)
Noble Capital Markets Senior Research Analyst Joe Gomes has initiated equity research coverage on MariMed (MRMD) with his report titled "A Cannabis Brands Company; Initiating Coverage"
Noble Capital Markets Initiates Equity Research Coverage on Gyre Therapeutics (GYRE)
Noble Capital Markets has initiated equity research coverage on Gyre Therapeutics (GYRE) with today's report, titled "Initiation of Coverage: Focused On Fibrosis"